Építés alatt – nem éles oldal
Belépés
Befejeződött2. fázis

LAMSA2020: “A phase II randomized study to assess the efficacy on outcome of Venetoclax combined with Cytarabine versus Idarubicin combined with Cytarabine administered as post-remission therapy to elderly patients with acute myeloid leukemia in first remission”

Key facts

Where
Angers Cedex 9, Avignon, Bayonne, Besancon Cedex, Béziers, Clermont-Ferrand, Grenoble Cedex 9, Lyon, Marseille, Metz Cedex 03, Montpellier Cedex 5, Mulhouse, Nantes, Nimes Cedex 9, Orleans Cedex 2, Perpignan Cedex, Pessac, Pringy Cedex, Reims Cedex, Rennes Cedex 9, Saint-Etienne Cedex 2, Strasbourg, Strasbourg Cedex 2, Toulouse Cedex 9, Tours Cedex 9 és Vandoeuvre Les Nancy, FranciaországSee the 26 sites
Phase
2. fázis

Where in Franciaország

  • Centre Hospitalier Universitaire D AngersAngers Cedex 9, FranciaországNo longer taking part
  • Centre Hospitalier d'AvignonAvignon, FranciaországNo longer taking part
  • Centre Hospitalier de la Cote BasqueBayonne, FranciaországNo longer taking part
  • Besancon University Hospital CenterBesancon Cedex, FranciaországNo longer taking part
  • Centre Hospitalier de BéziersBéziers, FranciaországNo longer taking part
  • University Hospital Of Clermont-FerrandClermont-Ferrand, FranciaországNo longer taking part
  • Centre Hospitalier Universitaire Grenoble AlpesGrenoble Cedex 9, FranciaországNo longer taking part
  • Centre Leon BerardLyon, FranciaországNo longer taking part
  • Institut Paoli-CalmettesMarseille, FranciaországNo longer taking part
  • Centre Hospital Region Metz ThionvilleMetz Cedex 03, FranciaországNo longer taking part
  • Hopital Saint EloiMontpellier Cedex 5, FranciaországNo longer taking part
  • Groupe Hospitalier de la Région de Mulhouse et Sud AlsaceMulhouse, FranciaországNo longer taking part
  • Centre Hospitalier Universitaire de NantesNantes, FranciaországNo longer taking part
  • Centre Hospitalier Universitaire De NimesNimes Cedex 9, FranciaországNo longer taking part
  • Centre Hospitalier Regional D'orleansOrleans Cedex 2, FranciaországNo longer taking part
  • Centre Hospitalier De PerpignanPerpignan Cedex, FranciaországNo longer taking part
  • Centre Hospitalier Universitaire de BordeauxPessac, FranciaországNo longer taking part
  • Centre Hospitalier Annecy GenevoisPringy Cedex, FranciaországNo longer taking part
  • Centre Hospitalier Universitaire De ReimsReims Cedex, FranciaországNo longer taking part
  • Centre Hospitalier Universitaire De RennesRennes Cedex 9, FranciaországNo longer taking part
  • Chu De Saint EtienneSaint-Etienne Cedex 2, FranciaországNo longer taking part
  • Institut de Cancérologie Strasbourg EuropeStrasbourg, FranciaországNo longer taking part
  • Les Hopitaux Universitaires De StrasbourgStrasbourg Cedex 2, FranciaországNo longer taking part
  • Centre Hospitalier Universitaire De ToulouseToulouse Cedex 9, FranciaországNo longer taking part
  • Centre Hospitalier Regional Universitaire De ToursTours Cedex 9, FranciaországNo longer taking part
  • CHRU De NancyVandoeuvre Les Nancy, FranciaországNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
French Innovative Leukemia Organization
Trial code
EU 2022-502392-37-00
Record updated
2025. szeptember 16.